irbesartan "jubilant" 150 mg filmovertrukne tabletter
jubilant pharmaceuticals nv - irbesartan - filmovertrukne tabletter - 150 mg
lamotrigin "bluefish" 100 mg tabletter
bluefish pharmaceuticals ab - lamotrigin - tabletter - 100 mg
lamotrigin "bluefish" 200 mg tabletter
bluefish pharmaceuticals ab - lamotrigin - tabletter - 200 mg
lamotrigin "bluefish" 50 mg tabletter
bluefish pharmaceuticals ab - lamotrigin - tabletter - 50 mg
losartan "bluefish" 100 mg filmovertrukne tabletter
bluefish pharmaceuticals ab - losartankalium - filmovertrukne tabletter - 100 mg
losartan "bluefish" 12,5 mg filmovertrukne tabletter
bluefish pharmaceuticals ab - losartankalium - filmovertrukne tabletter - 12,5 mg
losartan "bluefish" 50 mg filmovertrukne tabletter
bluefish pharmaceuticals ab - losartankalium - filmovertrukne tabletter - 50 mg
zopiclone "jubilant" 7,5 mg filmovertrukne tabletter
jubilant pharmaceuticals nv - zopiclon - filmovertrukne tabletter - 7,5 mg
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioødemer, arvelige - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.
firmagon
ferring pharmaceuticals a/s - degarelix - prostatiske neoplasmer - endokrine terapi - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.